ArticleBiomedicines2024

Gemtuzumab Ozogamicin and Stem Cell Mobilization for Autologous Stem Cell Transplantation in Favorable Risk Acute Myeloid Leukemia.

Danaë Martinez Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.